Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.
The Drugs for Malaria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.
The Drugs for Malaria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Drugs for Malaria Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Drugs for Malaria Market Size by Region (2019-2030)
1.4.1 Global Drugs for Malaria Market Size by Region (2019-2024)
1.4.2 Global Drugs for Malaria Market Size by Region (2025-2030)
1.5 Key Regions Drugs for Malaria Market Size (2019-2030)
1.5.1 North America Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.2 Europe Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.4 Latin America Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Drugs for Malaria Market Size Growth Rate (2019-2030)
2 DRUGS FOR MALARIA MARKET BY TYPE
2.1 Type Introduction
2.1.1 Aryl Aminoalcohol Compounds
2.1.2 Antifolate Compounds
2.1.3 Artemisinin Compounds
2.2 Global Drugs for Malaria Market Size by Type
2.2.1 Global Drugs for Malaria Market Size Overview by Type (2019-2030)
2.2.2 Global Drugs for Malaria Historic Market Size Review by Type (2019-2024)
2.2.3 Global Drugs for Malaria Market Size Forecasted by Type (2025-2030)
2.3 Global Drugs for Malaria Market Size by Regions
2.3.1 North America Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2019-2024)
3 DRUGS FOR MALARIA MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Prevention
3.1.2 Treatment
3.1.3 Others
3.2 Global Drugs for Malaria Market Size by Application
3.2.1 Global Drugs for Malaria Market Size Overview by Application (2019-2030)
3.2.2 Global Drugs for Malaria Historic Market Size Review by Application (2019-2024)
3.2.3 Global Drugs for Malaria Market Size Forecasted by Application (2025-2030)
3.3 Global Drugs for Malaria Market Size by Regions
3.3.1 North America Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Drugs for Malaria Industry Trends
4.2 Drugs for Malaria Industry Drivers
4.3 Drugs for Malaria Industry Opportunities and Challenges
4.4 Drugs for Malaria Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Drugs for Malaria Revenue (2019-2024)
5.2 Global Drugs for Malaria Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Drugs for Malaria Key Company Headquarters & Area Served
5.4 Global Drugs for Malaria Company, Product Type & Application
5.5 Global Drugs for Malaria Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Drugs for Malaria Market CR5 and HHI
5.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
5.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Cipla
6.1.1 Cipla Comapny Information
6.1.2 Cipla Business Overview
6.1.3 Cipla Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Cipla Drugs for Malaria Product Portfolio
6.1.5 Cipla Recent Developments
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Comapny Information
6.2.2 Guilin Pharmaceutical Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
6.2.5 Guilin Pharmaceutical Recent Developments
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Comapny Information
6.3.2 IPCA Laboratories Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
6.3.5 IPCA Laboratories Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Comapny Information
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments
6.5 Mylan Labs
6.5.1 Mylan Labs Comapny Information
6.5.2 Mylan Labs Business Overview
6.5.3 Mylan Labs Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
6.5.5 Mylan Labs Recent Developments
6.6 Roche
6.6.1 Roche Comapny Information
6.6.2 Roche Business Overview
6.6.3 Roche Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Roche Drugs for Malaria Product Portfolio
6.6.5 Roche Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Novartis Drugs for Malaria Product Portfolio
6.7.5 Novartis Recent Developments
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Comapny Information
6.8.2 Sanofi Aventis Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
6.8.5 Sanofi Aventis Recent Developments
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Comapny Information
6.9.2 Ajanta Pharma Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
6.9.5 Ajanta Pharma Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Drugs for Malaria Market Size by Country (2019-2024)
7.3 North America Drugs for Malaria Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.3 Europe Drugs for Malaria Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024)
9.3 Asia-Pacific Drugs for Malaria Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Drugs for Malaria Market Size by Country (2019-2024)
10.3 Latin America Drugs for Malaria Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024)
11.3 Middle East & Africa Drugs for Malaria Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Drugs for Malaria Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Drugs for Malaria Market Size by Region (2019-2030)
1.4.1 Global Drugs for Malaria Market Size by Region (2019-2024)
1.4.2 Global Drugs for Malaria Market Size by Region (2025-2030)
1.5 Key Regions Drugs for Malaria Market Size (2019-2030)
1.5.1 North America Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.2 Europe Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.4 Latin America Drugs for Malaria Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Drugs for Malaria Market Size Growth Rate (2019-2030)
2 DRUGS FOR MALARIA MARKET BY TYPE
2.1 Type Introduction
2.1.1 Aryl Aminoalcohol Compounds
2.1.2 Antifolate Compounds
2.1.3 Artemisinin Compounds
2.2 Global Drugs for Malaria Market Size by Type
2.2.1 Global Drugs for Malaria Market Size Overview by Type (2019-2030)
2.2.2 Global Drugs for Malaria Historic Market Size Review by Type (2019-2024)
2.2.3 Global Drugs for Malaria Market Size Forecasted by Type (2025-2030)
2.3 Global Drugs for Malaria Market Size by Regions
2.3.1 North America Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Drugs for Malaria Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2019-2024)
3 DRUGS FOR MALARIA MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Prevention
3.1.2 Treatment
3.1.3 Others
3.2 Global Drugs for Malaria Market Size by Application
3.2.1 Global Drugs for Malaria Market Size Overview by Application (2019-2030)
3.2.2 Global Drugs for Malaria Historic Market Size Review by Application (2019-2024)
3.2.3 Global Drugs for Malaria Market Size Forecasted by Application (2025-2030)
3.3 Global Drugs for Malaria Market Size by Regions
3.3.1 North America Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Drugs for Malaria Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Drugs for Malaria Industry Trends
4.2 Drugs for Malaria Industry Drivers
4.3 Drugs for Malaria Industry Opportunities and Challenges
4.4 Drugs for Malaria Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Drugs for Malaria Revenue (2019-2024)
5.2 Global Drugs for Malaria Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Drugs for Malaria Key Company Headquarters & Area Served
5.4 Global Drugs for Malaria Company, Product Type & Application
5.5 Global Drugs for Malaria Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Drugs for Malaria Market CR5 and HHI
5.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
5.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Cipla
6.1.1 Cipla Comapny Information
6.1.2 Cipla Business Overview
6.1.3 Cipla Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Cipla Drugs for Malaria Product Portfolio
6.1.5 Cipla Recent Developments
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Comapny Information
6.2.2 Guilin Pharmaceutical Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
6.2.5 Guilin Pharmaceutical Recent Developments
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Comapny Information
6.3.2 IPCA Laboratories Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
6.3.5 IPCA Laboratories Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Comapny Information
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments
6.5 Mylan Labs
6.5.1 Mylan Labs Comapny Information
6.5.2 Mylan Labs Business Overview
6.5.3 Mylan Labs Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
6.5.5 Mylan Labs Recent Developments
6.6 Roche
6.6.1 Roche Comapny Information
6.6.2 Roche Business Overview
6.6.3 Roche Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Roche Drugs for Malaria Product Portfolio
6.6.5 Roche Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Novartis Drugs for Malaria Product Portfolio
6.7.5 Novartis Recent Developments
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Comapny Information
6.8.2 Sanofi Aventis Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
6.8.5 Sanofi Aventis Recent Developments
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Comapny Information
6.9.2 Ajanta Pharma Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
6.9.5 Ajanta Pharma Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Drugs for Malaria Market Size by Country (2019-2024)
7.3 North America Drugs for Malaria Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.3 Europe Drugs for Malaria Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024)
9.3 Asia-Pacific Drugs for Malaria Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Drugs for Malaria Market Size by Country (2019-2024)
10.3 Latin America Drugs for Malaria Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024)
11.3 Middle East & Africa Drugs for Malaria Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Drugs for Malaria Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 4. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 6. Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Drugs for Malaria Market Size Share by Type (2019-2024)
Table 9. Global Drugs for Malaria Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Drugs for Malaria Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Drugs for Malaria Market Size Share by Application (2019-2024)
Table 24. Global Drugs for Malaria Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Drugs for Malaria Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Drugs for Malaria Industry Trends
Table 37. Drugs for Malaria Industry Drivers
Table 38. Drugs for Malaria Industry Opportunities and Challenges
Table 39. Drugs for Malaria Industry Restraints
Table 40. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Drugs for Malaria Revenue Market Share by Company (2019-2024)
Table 42. Global Drugs for Malaria Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Drugs for Malaria Key Company Headquarters & Area Served
Table 44. Global Drugs for Malaria Company, Product Type & Application
Table 45. Global Drugs for Malaria Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Cipla Business Overview
Table 49. Cipla Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Cipla Drugs for Malaria Product Portfolio
Table 51. Cipla Recent Development
Table 52. Guilin Pharmaceutical Company Information
Table 53. Guilin Pharmaceutical Business Overview
Table 54. Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 56. Guilin Pharmaceutical Recent Development
Table 57. IPCA Laboratories Company Information
Table 58. IPCA Laboratories Business Overview
Table 59. IPCA Laboratories Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 61. IPCA Laboratories Recent Development
Table 62. GlaxoSmithKline Company Information
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 66. GlaxoSmithKline Recent Development
Table 67. Mylan Labs Company Information
Table 68. Mylan Labs Business Overview
Table 69. Mylan Labs Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Mylan Labs Drugs for Malaria Product Portfolio
Table 71. Mylan Labs Recent Development
Table 72. Roche Company Information
Table 73. Roche Business Overview
Table 74. Roche Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Roche Drugs for Malaria Product Portfolio
Table 76. Roche Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Business Overview
Table 79. Novartis Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Novartis Drugs for Malaria Product Portfolio
Table 81. Novartis Recent Development
Table 82. Sanofi Aventis Company Information
Table 83. Sanofi Aventis Business Overview
Table 84. Sanofi Aventis Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 86. Sanofi Aventis Recent Development
Table 87. Ajanta Pharma Company Information
Table 88. Ajanta Pharma Business Overview
Table 89. Ajanta Pharma Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 91. Ajanta Pharma Recent Development
Table 92. North America Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 93. North America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 94. North America Drugs for Malaria Market Share by Country (2019-2024)
Table 95. North America Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 96. North America Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 97. Europe Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 98. Europe Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 99. Europe Drugs for Malaria Market Share by Country (2019-2024)
Table 100. Europe Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 101. Europe Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 102. Asia-Pacific Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 104. Asia-Pacific Drugs for Malaria Market Share by Country (2019-2024)
Table 105. Asia-Pacific Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. Asia-Pacific Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 107. Latin America Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Latin America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 109. Latin America Drugs for Malaria Market Share by Country (2019-2024)
Table 110. Latin America Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Latin America Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 112. Middle East & Africa Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 114. Middle East & Africa Drugs for Malaria Market Share by Country (2019-2024)
Table 115. Middle East & Africa Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Middle East & Africa Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 117. Research Programs/Design for This Report
Table 118. Authors List of This Report
Table 119. Secondary Sources
Table 120. Primary Sources
Table 1. Global Drugs for Malaria Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 4. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 6. Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Drugs for Malaria Market Size Share by Type (2019-2024)
Table 9. Global Drugs for Malaria Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Drugs for Malaria Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Drugs for Malaria Market Size Share by Application (2019-2024)
Table 24. Global Drugs for Malaria Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Drugs for Malaria Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Drugs for Malaria Industry Trends
Table 37. Drugs for Malaria Industry Drivers
Table 38. Drugs for Malaria Industry Opportunities and Challenges
Table 39. Drugs for Malaria Industry Restraints
Table 40. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Drugs for Malaria Revenue Market Share by Company (2019-2024)
Table 42. Global Drugs for Malaria Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Drugs for Malaria Key Company Headquarters & Area Served
Table 44. Global Drugs for Malaria Company, Product Type & Application
Table 45. Global Drugs for Malaria Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Cipla Business Overview
Table 49. Cipla Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Cipla Drugs for Malaria Product Portfolio
Table 51. Cipla Recent Development
Table 52. Guilin Pharmaceutical Company Information
Table 53. Guilin Pharmaceutical Business Overview
Table 54. Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 56. Guilin Pharmaceutical Recent Development
Table 57. IPCA Laboratories Company Information
Table 58. IPCA Laboratories Business Overview
Table 59. IPCA Laboratories Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 61. IPCA Laboratories Recent Development
Table 62. GlaxoSmithKline Company Information
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 66. GlaxoSmithKline Recent Development
Table 67. Mylan Labs Company Information
Table 68. Mylan Labs Business Overview
Table 69. Mylan Labs Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Mylan Labs Drugs for Malaria Product Portfolio
Table 71. Mylan Labs Recent Development
Table 72. Roche Company Information
Table 73. Roche Business Overview
Table 74. Roche Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Roche Drugs for Malaria Product Portfolio
Table 76. Roche Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Business Overview
Table 79. Novartis Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Novartis Drugs for Malaria Product Portfolio
Table 81. Novartis Recent Development
Table 82. Sanofi Aventis Company Information
Table 83. Sanofi Aventis Business Overview
Table 84. Sanofi Aventis Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 86. Sanofi Aventis Recent Development
Table 87. Ajanta Pharma Company Information
Table 88. Ajanta Pharma Business Overview
Table 89. Ajanta Pharma Drugs for Malaria Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 91. Ajanta Pharma Recent Development
Table 92. North America Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 93. North America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 94. North America Drugs for Malaria Market Share by Country (2019-2024)
Table 95. North America Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 96. North America Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 97. Europe Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 98. Europe Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 99. Europe Drugs for Malaria Market Share by Country (2019-2024)
Table 100. Europe Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 101. Europe Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 102. Asia-Pacific Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 104. Asia-Pacific Drugs for Malaria Market Share by Country (2019-2024)
Table 105. Asia-Pacific Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. Asia-Pacific Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 107. Latin America Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Latin America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 109. Latin America Drugs for Malaria Market Share by Country (2019-2024)
Table 110. Latin America Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Latin America Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 112. Middle East & Africa Drugs for Malaria Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)
Table 114. Middle East & Africa Drugs for Malaria Market Share by Country (2019-2024)
Table 115. Middle East & Africa Drugs for Malaria Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Middle East & Africa Drugs for Malaria Market Share Forecast by Country (2025-2030)
Table 117. Research Programs/Design for This Report
Table 118. Authors List of This Report
Table 119. Secondary Sources
Table 120. Primary Sources
LIST OF FIGURES
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Malaria Market Share by Region: 2023 VS 2030
Figure 5. Global Drugs for Malaria Market Share by Region (2019-2030)
Figure 6. North America Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Aryl Aminoalcohol Compounds
Figure 12. Global Aryl Aminoalcohol Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Antifolate Compounds
Figure 14. Global Antifolate Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Artemisinin Compounds
Figure 16. Global Artemisinin Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Global Drugs for Malaria Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 18. Global Drugs for Malaria Market Share by Type 2023 VS 2030
Figure 19. North America Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 20. Europe Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 21. Asia-Pacific Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 22. Latin America Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 23. Middle East and Africa Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 24. Product Picture of Prevention
Figure 25. Global Prevention Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Treatment
Figure 27. Global Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Others
Figure 29. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Global Drugs for Malaria Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 31. Global Drugs for Malaria Market Share by Application 2023 VS 2030
Figure 32. North America Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 33. Europe Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 34. Asia-Pacific Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 35. Latin America Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 36. Middle East and Africa Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 37. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
Figure 38. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 39. North America Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 40. North America Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Drugs for Malaria Market Share by Country (2019-2030)
Figure 42. Europe Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 43. Europe Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 44. Europe Drugs for Malaria Market Share by Country (2019-2030)
Figure 45. Asia-Pacific Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Asia-Pacific Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Drugs for Malaria Market Share by Country (2019-2030)
Figure 48. Latin America Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 49. Latin America Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 50. Latin America Drugs for Malaria Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Middle East & Africa Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Middle East & Africa Drugs for Malaria Market Share by Country (2019-2030)
Figure 54. Years Considered
Figure 55. Research Process
Figure 56. Key Executives Interviewed
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Malaria Market Share by Region: 2023 VS 2030
Figure 5. Global Drugs for Malaria Market Share by Region (2019-2030)
Figure 6. North America Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Drugs for Malaria Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Aryl Aminoalcohol Compounds
Figure 12. Global Aryl Aminoalcohol Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Antifolate Compounds
Figure 14. Global Antifolate Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Artemisinin Compounds
Figure 16. Global Artemisinin Compounds Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Global Drugs for Malaria Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 18. Global Drugs for Malaria Market Share by Type 2023 VS 2030
Figure 19. North America Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 20. Europe Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 21. Asia-Pacific Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 22. Latin America Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 23. Middle East and Africa Drugs for Malaria Market Size Share by Type (2019-2030)
Figure 24. Product Picture of Prevention
Figure 25. Global Prevention Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Treatment
Figure 27. Global Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Others
Figure 29. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Global Drugs for Malaria Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 31. Global Drugs for Malaria Market Share by Application 2023 VS 2030
Figure 32. North America Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 33. Europe Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 34. Asia-Pacific Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 35. Latin America Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 36. Middle East and Africa Drugs for Malaria Market Size Share by Application (2019-2030)
Figure 37. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
Figure 38. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 39. North America Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 40. North America Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Drugs for Malaria Market Share by Country (2019-2030)
Figure 42. Europe Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 43. Europe Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 44. Europe Drugs for Malaria Market Share by Country (2019-2030)
Figure 45. Asia-Pacific Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Asia-Pacific Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Drugs for Malaria Market Share by Country (2019-2030)
Figure 48. Latin America Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 49. Latin America Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 50. Latin America Drugs for Malaria Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Drugs for Malaria Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Middle East & Africa Drugs for Malaria Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Middle East & Africa Drugs for Malaria Market Share by Country (2019-2030)
Figure 54. Years Considered
Figure 55. Research Process
Figure 56. Key Executives Interviewed
